Curcumin turmeric (C. longa) has been found capable of inhibiting p300/CBP associated factor (PCAF) histone asetyltransferase (HAT) as a cancer biomarker. However, the molecular mechanism of inhibition is unkown. This study is aimed to analyse the molecular inhibition mechanisms by in silico method. The analysis showed that curcumin’s Gibbs free energy (ΔG) was stable and capable of binding amino acid residues believed to be active site of PCAF HAT. Curcumin is predicted to be a PCAF HAT inhibitor, and further in vitro analysis is required
Curcumin is a compound having broad spectrum of biological activities for example as anti-cancer. Th...
Curcumin has been shown to be active against various cancers and it has also been seen to exhibit go...
This study investigated the inhibitory effects of curcumin on proliferation of hematological maligna...
Cancer is one of the death causes in the world. Many plants act as anticancer, one of them is Curcum...
Stress conditions will trigger the histone hyperacetylation process due to histone acetyltransferase...
Objective: The objective of this research was to show quercetin potency to inhibit histone acetyltra...
Curcumin, isolated from Curcuma longa L, long enough being used for medicinal purposes in Asia\ud to...
Curcumin, the major compound of Curcuma longa L, has been proven to have the toxicity effect on pros...
In this research, the in silico interaction between curcumin and cyclooxygenase 2 (COX-2) was invest...
Cancer is the main cause of death in developing countries. In Indonesia, breast cancer patients rank...
Abstract Background Curcuma longa (Turmeric) is a traditionally used herb in wound healing. The effi...
Background The anti-tumor properties of curcumin have been demonstrated for many types of cancer. Ho...
Malignant disease or cancer progression burden the community after decades. This tumor formation or ...
Curcumin derivatives which are very potent antioxidant, free radical scavenger and known inhibitor o...
Copyright © 2012 A. Kumar and U. Bora. This is an open access article distributed under the Creative...
Curcumin is a compound having broad spectrum of biological activities for example as anti-cancer. Th...
Curcumin has been shown to be active against various cancers and it has also been seen to exhibit go...
This study investigated the inhibitory effects of curcumin on proliferation of hematological maligna...
Cancer is one of the death causes in the world. Many plants act as anticancer, one of them is Curcum...
Stress conditions will trigger the histone hyperacetylation process due to histone acetyltransferase...
Objective: The objective of this research was to show quercetin potency to inhibit histone acetyltra...
Curcumin, isolated from Curcuma longa L, long enough being used for medicinal purposes in Asia\ud to...
Curcumin, the major compound of Curcuma longa L, has been proven to have the toxicity effect on pros...
In this research, the in silico interaction between curcumin and cyclooxygenase 2 (COX-2) was invest...
Cancer is the main cause of death in developing countries. In Indonesia, breast cancer patients rank...
Abstract Background Curcuma longa (Turmeric) is a traditionally used herb in wound healing. The effi...
Background The anti-tumor properties of curcumin have been demonstrated for many types of cancer. Ho...
Malignant disease or cancer progression burden the community after decades. This tumor formation or ...
Curcumin derivatives which are very potent antioxidant, free radical scavenger and known inhibitor o...
Copyright © 2012 A. Kumar and U. Bora. This is an open access article distributed under the Creative...
Curcumin is a compound having broad spectrum of biological activities for example as anti-cancer. Th...
Curcumin has been shown to be active against various cancers and it has also been seen to exhibit go...
This study investigated the inhibitory effects of curcumin on proliferation of hematological maligna...